InvestorsHub Logo
Followers 195
Posts 24599
Boards Moderated 0
Alias Born 04/03/2010

Re: learningcurve2020 post# 84232

Saturday, 11/19/2016 5:58:49 PM

Saturday, November 19, 2016 5:58:49 PM

Post# of 696922
1. It's not a hedge fund and this is not the focus of their funds;
2. I think really experienced investors recognize the vulnerable nature of start-ups with revolutionary technologies that need shepherding, and the dangers of what you suggest. Sharks do what you say, sometimes, but not always. In this case, I don't think that would have been the best thing to do. I don't like takeovers myself, with companies like this. It usually ruins just about everything, though you can rescue some cash out of it.

I'd rather my companies fail or succeed on the purity of their efforts. The successes more than pay for failures.

Hostile takeovers usually are followed by clueless executives and replacement scientists recruited from the bottom of the heap. That would not advance the science, nor the cure, and I think they'd be hated in the biotech community if they did that too often, or even once, with a company or technology as closely watched as this one. Their reputations would suffer. And I don't think they think it's necessary, or has been necessary.

Of course, they might change their mind once the tech is proven, but I sincerely hope not. I think, given the structure, it would not be ideal, though I also think they've structured the assets and company such that a hostile takeover is less likely than a friendly one. I don't always love those either. As I said, I like the pure and full ride.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News